nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Dinoprostone—PTGER4—multiple sclerosis	0.00831	1	CrCbGaD
Bimatoprost—Hypertension—Fingolimod—multiple sclerosis	0.00255	0.00511	CcSEcCtD
Bimatoprost—Stinging—Prednisolone—multiple sclerosis	0.00254	0.00511	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00249	0.00501	CcSEcCtD
Bimatoprost—Eye irritation—Prednisolone—multiple sclerosis	0.00241	0.00485	CcSEcCtD
Bimatoprost—Infection—Fingolimod—multiple sclerosis	0.00239	0.0048	CcSEcCtD
Bimatoprost—Nervous system disorder—Fingolimod—multiple sclerosis	0.00236	0.00474	CcSEcCtD
Bimatoprost—Stinging—Triamcinolone—multiple sclerosis	0.00234	0.0047	CcSEcCtD
Bimatoprost—Skin disorder—Fingolimod—multiple sclerosis	0.00234	0.00469	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00223	0.00448	CcSEcCtD
Bimatoprost—Dyspnoea—Fingolimod—multiple sclerosis	0.00215	0.00431	CcSEcCtD
Bimatoprost—Stinging—Betamethasone—multiple sclerosis	0.00212	0.00426	CcSEcCtD
Bimatoprost—Stinging—Dexamethasone—multiple sclerosis	0.00212	0.00426	CcSEcCtD
Bimatoprost—Skin hyperpigmentation—Methotrexate—multiple sclerosis	0.0021	0.00423	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00208	0.00417	CcSEcCtD
Bimatoprost—Cough increased—Triamcinolone—multiple sclerosis	0.00207	0.00416	CcSEcCtD
Bimatoprost—Cataract—Triamcinolone—multiple sclerosis	0.00199	0.004	CcSEcCtD
Bimatoprost—Inflammation—Methylprednisolone—multiple sclerosis	0.00195	0.00392	CcSEcCtD
Bimatoprost—Pharyngitis—Cladribine—multiple sclerosis	0.00191	0.00383	CcSEcCtD
Bimatoprost—Oedema peripheral—Cladribine—multiple sclerosis	0.00189	0.0038	CcSEcCtD
Bimatoprost—Connective tissue disorder—Cladribine—multiple sclerosis	0.00189	0.00379	CcSEcCtD
Bimatoprost—Cataract—Dexamethasone—multiple sclerosis	0.00181	0.00363	CcSEcCtD
Bimatoprost—Cataract—Betamethasone—multiple sclerosis	0.00181	0.00363	CcSEcCtD
Bimatoprost—Burning sensation—Methotrexate—multiple sclerosis	0.0018	0.00362	CcSEcCtD
Bimatoprost—Eye disorder—Cladribine—multiple sclerosis	0.00179	0.0036	CcSEcCtD
Bimatoprost—Angiopathy—Cladribine—multiple sclerosis	0.00174	0.0035	CcSEcCtD
Bimatoprost—Mediastinal disorder—Cladribine—multiple sclerosis	0.00173	0.00348	CcSEcCtD
Bimatoprost—Asthenia—Fingolimod—multiple sclerosis	0.00173	0.00347	CcSEcCtD
Bimatoprost—Pruritus—Fingolimod—multiple sclerosis	0.0017	0.00342	CcSEcCtD
Bimatoprost—Erythema—Cladribine—multiple sclerosis	0.00167	0.00336	CcSEcCtD
Bimatoprost—Dizziness—Fingolimod—multiple sclerosis	0.00159	0.0032	CcSEcCtD
Bimatoprost—Dry eye—Betamethasone—multiple sclerosis	0.00159	0.00319	CcSEcCtD
Bimatoprost—Dry eye—Dexamethasone—multiple sclerosis	0.00159	0.00319	CcSEcCtD
Bimatoprost—Hypercholesterolaemia—Prednisone—multiple sclerosis	0.00158	0.00318	CcSEcCtD
Bimatoprost—Visual disturbance—Prednisolone—multiple sclerosis	0.00158	0.00317	CcSEcCtD
Bimatoprost—Cataract—Prednisone—multiple sclerosis	0.00157	0.00316	CcSEcCtD
Bimatoprost—Headache—Fingolimod—multiple sclerosis	0.00151	0.00303	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00147	0.00294	CcSEcCtD
Bimatoprost—Cough—Cladribine—multiple sclerosis	0.00146	0.00293	CcSEcCtD
Bimatoprost—Chest pain—Cladribine—multiple sclerosis	0.00142	0.00286	CcSEcCtD
Bimatoprost—Anxiety—Cladribine—multiple sclerosis	0.00142	0.00285	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00141	0.00284	CcSEcCtD
Bimatoprost—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00141	0.00283	CcSEcCtD
Bimatoprost—Skin discolouration—Methotrexate—multiple sclerosis	0.00139	0.00278	CcSEcCtD
Bimatoprost—Eye pain—Dexamethasone—multiple sclerosis	0.00138	0.00278	CcSEcCtD
Bimatoprost—Eye pain—Betamethasone—multiple sclerosis	0.00138	0.00278	CcSEcCtD
Bimatoprost—Dry skin—Prednisolone—multiple sclerosis	0.00137	0.00276	CcSEcCtD
Bimatoprost—Infection—Cladribine—multiple sclerosis	0.00136	0.00272	CcSEcCtD
Bimatoprost—Nervous system disorder—Cladribine—multiple sclerosis	0.00134	0.00269	CcSEcCtD
Bimatoprost—Skin disorder—Cladribine—multiple sclerosis	0.00132	0.00266	CcSEcCtD
Bimatoprost—Sinusitis—Mitoxantrone—multiple sclerosis	0.00132	0.00265	CcSEcCtD
Bimatoprost—Visual disturbance—Betamethasone—multiple sclerosis	0.00132	0.00265	CcSEcCtD
Bimatoprost—Visual disturbance—Dexamethasone—multiple sclerosis	0.00132	0.00265	CcSEcCtD
Bimatoprost—Inflammation—Methotrexate—multiple sclerosis	0.00129	0.00259	CcSEcCtD
Bimatoprost—Rhinitis—Mitoxantrone—multiple sclerosis	0.00127	0.00254	CcSEcCtD
Bimatoprost—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00125	0.00252	CcSEcCtD
Bimatoprost—Insomnia—Cladribine—multiple sclerosis	0.00123	0.00248	CcSEcCtD
Bimatoprost—Cystitis noninfective—Methotrexate—multiple sclerosis	0.00122	0.00246	CcSEcCtD
Bimatoprost—Dyspnoea—Cladribine—multiple sclerosis	0.00122	0.00244	CcSEcCtD
Bimatoprost—Somnolence—Cladribine—multiple sclerosis	0.00121	0.00244	CcSEcCtD
Bimatoprost—Cystitis—Methotrexate—multiple sclerosis	0.00121	0.00243	CcSEcCtD
Bimatoprost—Asthma—Triamcinolone—multiple sclerosis	0.00119	0.00239	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00118	0.00237	CcSEcCtD
Bimatoprost—Pain—Cladribine—multiple sclerosis	0.00117	0.00234	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00115	0.00231	CcSEcCtD
Bimatoprost—Dry skin—Dexamethasone—multiple sclerosis	0.00114	0.0023	CcSEcCtD
Bimatoprost—Dry skin—Betamethasone—multiple sclerosis	0.00114	0.0023	CcSEcCtD
Bimatoprost—Bronchitis—Triamcinolone—multiple sclerosis	0.00114	0.0023	CcSEcCtD
Bimatoprost—Bladder pain—Methotrexate—multiple sclerosis	0.00113	0.00227	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00111	0.00222	CcSEcCtD
Bimatoprost—Infection—Azathioprine—multiple sclerosis	0.0011	0.00221	CcSEcCtD
Bimatoprost—Erythema—Mitoxantrone—multiple sclerosis	0.0011	0.00221	CcSEcCtD
Bimatoprost—Skin disorder—Azathioprine—multiple sclerosis	0.00108	0.00216	CcSEcCtD
Bimatoprost—Vision blurred—Mitoxantrone—multiple sclerosis	0.00104	0.00208	CcSEcCtD
Bimatoprost—Visual impairment—Prednisolone—multiple sclerosis	0.000998	0.002	CcSEcCtD
Bimatoprost—Dry skin—Prednisone—multiple sclerosis	0.000997	0.002	CcSEcCtD
Bimatoprost—Asthenia—Cladribine—multiple sclerosis	0.000979	0.00197	CcSEcCtD
Bimatoprost—Pruritus—Cladribine—multiple sclerosis	0.000965	0.00194	CcSEcCtD
Bimatoprost—Visual disturbance—Methotrexate—multiple sclerosis	0.000959	0.00193	CcSEcCtD
Bimatoprost—Cough—Mitoxantrone—multiple sclerosis	0.000959	0.00193	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000957	0.00192	CcSEcCtD
Bimatoprost—Rhinitis—Triamcinolone—multiple sclerosis	0.000954	0.00192	CcSEcCtD
Bimatoprost—Rhinitis—Methylprednisolone—multiple sclerosis	0.000952	0.00191	CcSEcCtD
Bimatoprost—Hypertension—Mitoxantrone—multiple sclerosis	0.000948	0.0019	CcSEcCtD
Bimatoprost—Pharyngitis—Triamcinolone—multiple sclerosis	0.000945	0.0019	CcSEcCtD
Bimatoprost—Chest pain—Mitoxantrone—multiple sclerosis	0.000935	0.00188	CcSEcCtD
Bimatoprost—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000933	0.00187	CcSEcCtD
Bimatoprost—Anxiety—Mitoxantrone—multiple sclerosis	0.000932	0.00187	CcSEcCtD
Bimatoprost—Visual impairment—Methylprednisolone—multiple sclerosis	0.000915	0.00184	CcSEcCtD
Bimatoprost—Dizziness—Cladribine—multiple sclerosis	0.000902	0.00181	CcSEcCtD
Bimatoprost—Erythema—Prednisolone—multiple sclerosis	0.000901	0.00181	CcSEcCtD
Bimatoprost—Infection—Mitoxantrone—multiple sclerosis	0.000891	0.00179	CcSEcCtD
Bimatoprost—Eye disorder—Methylprednisolone—multiple sclerosis	0.000888	0.00178	CcSEcCtD
Bimatoprost—Skin disorder—Mitoxantrone—multiple sclerosis	0.000871	0.00175	CcSEcCtD
Bimatoprost—Angiopathy—Methylprednisolone—multiple sclerosis	0.000862	0.00173	CcSEcCtD
Bimatoprost—Rash—Cladribine—multiple sclerosis	0.00086	0.00173	CcSEcCtD
Bimatoprost—Dermatitis—Cladribine—multiple sclerosis	0.000859	0.00173	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000856	0.00172	CcSEcCtD
Bimatoprost—Headache—Cladribine—multiple sclerosis	0.000854	0.00172	CcSEcCtD
Bimatoprost—Vision blurred—Prednisolone—multiple sclerosis	0.000849	0.00171	CcSEcCtD
Bimatoprost—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000839	0.00169	CcSEcCtD
Bimatoprost—Depression—Prednisone—multiple sclerosis	0.000836	0.00168	CcSEcCtD
Bimatoprost—Visual impairment—Dexamethasone—multiple sclerosis	0.000832	0.00167	CcSEcCtD
Bimatoprost—Visual impairment—Betamethasone—multiple sclerosis	0.000832	0.00167	CcSEcCtD
Bimatoprost—Erythema—Triamcinolone—multiple sclerosis	0.000829	0.00166	CcSEcCtD
Bimatoprost—Erythema—Methylprednisolone—multiple sclerosis	0.000827	0.00166	CcSEcCtD
Bimatoprost—Nausea—Cladribine—multiple sclerosis	0.00081	0.00163	CcSEcCtD
Bimatoprost—Vertigo—Prednisolone—multiple sclerosis	0.00081	0.00163	CcSEcCtD
Bimatoprost—Eye disorder—Betamethasone—multiple sclerosis	0.000807	0.00162	CcSEcCtD
Bimatoprost—Eye disorder—Dexamethasone—multiple sclerosis	0.000807	0.00162	CcSEcCtD
Bimatoprost—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000799	0.00161	CcSEcCtD
Bimatoprost—Somnolence—Mitoxantrone—multiple sclerosis	0.000797	0.0016	CcSEcCtD
Bimatoprost—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000789	0.00159	CcSEcCtD
Bimatoprost—Asthma—Methotrexate—multiple sclerosis	0.000785	0.00158	CcSEcCtD
Bimatoprost—Angiopathy—Dexamethasone—multiple sclerosis	0.000784	0.00157	CcSEcCtD
Bimatoprost—Angiopathy—Betamethasone—multiple sclerosis	0.000784	0.00157	CcSEcCtD
Bimatoprost—Hypertension—Prednisolone—multiple sclerosis	0.000778	0.00156	CcSEcCtD
Bimatoprost—Pain—Mitoxantrone—multiple sclerosis	0.000767	0.00154	CcSEcCtD
Bimatoprost—Erythema—Dexamethasone—multiple sclerosis	0.000752	0.00151	CcSEcCtD
Bimatoprost—Erythema—Betamethasone—multiple sclerosis	0.000752	0.00151	CcSEcCtD
Bimatoprost—Vertigo—Triamcinolone—multiple sclerosis	0.000745	0.0015	CcSEcCtD
Bimatoprost—Vertigo—Methylprednisolone—multiple sclerosis	0.000743	0.00149	CcSEcCtD
Bimatoprost—Connective tissue disorder—Prednisone—multiple sclerosis	0.000739	0.00148	CcSEcCtD
Bimatoprost—Dizziness—Azathioprine—multiple sclerosis	0.000733	0.00147	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00073	0.00147	CcSEcCtD
Bimatoprost—Cough—Triamcinolone—multiple sclerosis	0.000723	0.00145	CcSEcCtD
Bimatoprost—Hypertension—Triamcinolone—multiple sclerosis	0.000716	0.00144	CcSEcCtD
Bimatoprost—Hypertension—Methylprednisolone—multiple sclerosis	0.000714	0.00143	CcSEcCtD
Bimatoprost—Eye disorder—Prednisone—multiple sclerosis	0.000703	0.00141	CcSEcCtD
Bimatoprost—Anxiety—Methylprednisolone—multiple sclerosis	0.000702	0.00141	CcSEcCtD
Bimatoprost—Rash—Azathioprine—multiple sclerosis	0.000699	0.0014	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000699	0.0014	CcSEcCtD
Bimatoprost—Dermatitis—Azathioprine—multiple sclerosis	0.000699	0.0014	CcSEcCtD
Bimatoprost—Depression—Methotrexate—multiple sclerosis	0.000698	0.0014	CcSEcCtD
Bimatoprost—Headache—Azathioprine—multiple sclerosis	0.000695	0.0014	CcSEcCtD
Bimatoprost—Dry mouth—Triamcinolone—multiple sclerosis	0.00069	0.00139	CcSEcCtD
Bimatoprost—Angiopathy—Prednisone—multiple sclerosis	0.000683	0.00137	CcSEcCtD
Bimatoprost—Vertigo—Betamethasone—multiple sclerosis	0.000676	0.00136	CcSEcCtD
Bimatoprost—Vertigo—Dexamethasone—multiple sclerosis	0.000676	0.00136	CcSEcCtD
Bimatoprost—Infection—Triamcinolone—multiple sclerosis	0.000672	0.00135	CcSEcCtD
Bimatoprost—Infection—Methylprednisolone—multiple sclerosis	0.00067	0.00135	CcSEcCtD
Bimatoprost—Insomnia—Prednisolone—multiple sclerosis	0.000665	0.00134	CcSEcCtD
Bimatoprost—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000662	0.00133	CcSEcCtD
Bimatoprost—Nausea—Azathioprine—multiple sclerosis	0.000659	0.00132	CcSEcCtD
Bimatoprost—Skin disorder—Methylprednisolone—multiple sclerosis	0.000656	0.00132	CcSEcCtD
Bimatoprost—Erythema—Prednisone—multiple sclerosis	0.000655	0.00132	CcSEcCtD
Bimatoprost—Hypertension—Betamethasone—multiple sclerosis	0.000649	0.0013	CcSEcCtD
Bimatoprost—Hypertension—Dexamethasone—multiple sclerosis	0.000649	0.0013	CcSEcCtD
Bimatoprost—Asthenia—Mitoxantrone—multiple sclerosis	0.000643	0.00129	CcSEcCtD
Bimatoprost—Anxiety—Dexamethasone—multiple sclerosis	0.000638	0.00128	CcSEcCtD
Bimatoprost—Anxiety—Betamethasone—multiple sclerosis	0.000638	0.00128	CcSEcCtD
Bimatoprost—Pain—Prednisolone—multiple sclerosis	0.000629	0.00126	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—multiple sclerosis	0.000624	0.00125	CcSEcCtD
Bimatoprost—Vision blurred—Prednisone—multiple sclerosis	0.000617	0.00124	CcSEcCtD
Bimatoprost—Insomnia—Triamcinolone—multiple sclerosis	0.000612	0.00123	CcSEcCtD
Bimatoprost—Insomnia—Methylprednisolone—multiple sclerosis	0.00061	0.00123	CcSEcCtD
Bimatoprost—Infection—Dexamethasone—multiple sclerosis	0.00061	0.00122	CcSEcCtD
Bimatoprost—Infection—Betamethasone—multiple sclerosis	0.00061	0.00122	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—multiple sclerosis	0.000606	0.00122	CcSEcCtD
Bimatoprost—Dyspnoea—Triamcinolone—multiple sclerosis	0.000603	0.00121	CcSEcCtD
Bimatoprost—Nervous system disorder—Betamethasone—multiple sclerosis	0.000602	0.00121	CcSEcCtD
Bimatoprost—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000602	0.00121	CcSEcCtD
Bimatoprost—Dyspepsia—Triamcinolone—multiple sclerosis	0.000595	0.0012	CcSEcCtD
Bimatoprost—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000594	0.00119	CcSEcCtD
Bimatoprost—Vertigo—Prednisone—multiple sclerosis	0.000588	0.00118	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—multiple sclerosis	0.000588	0.00118	CcSEcCtD
Bimatoprost—Pain—Triamcinolone—multiple sclerosis	0.000578	0.00116	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—multiple sclerosis	0.00057	0.00115	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000567	0.00114	CcSEcCtD
Bimatoprost—Hypertension—Prednisone—multiple sclerosis	0.000565	0.00114	CcSEcCtD
Bimatoprost—Rash—Mitoxantrone—multiple sclerosis	0.000565	0.00114	CcSEcCtD
Bimatoprost—Dermatitis—Mitoxantrone—multiple sclerosis	0.000565	0.00113	CcSEcCtD
Bimatoprost—Headache—Mitoxantrone—multiple sclerosis	0.000562	0.00113	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL13—multiple sclerosis	0.000559	0.00113	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LINGO1—multiple sclerosis	0.000558	0.00113	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000557	0.00113	CbGpPWpGaD
Bimatoprost—Anxiety—Prednisone—multiple sclerosis	0.000556	0.00112	CcSEcCtD
Bimatoprost—Insomnia—Dexamethasone—multiple sclerosis	0.000555	0.00111	CcSEcCtD
Bimatoprost—Insomnia—Betamethasone—multiple sclerosis	0.000555	0.00111	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000554	0.00111	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCR1—multiple sclerosis	0.000547	0.00111	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000547	0.00111	CbGpPWpGaD
Bimatoprost—Erythema—Methotrexate—multiple sclerosis	0.000547	0.0011	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000546	0.0011	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000545	0.0011	CbGpPWpGaD
Bimatoprost—Dyspepsia—Dexamethasone—multiple sclerosis	0.00054	0.00109	CcSEcCtD
Bimatoprost—Dyspepsia—Betamethasone—multiple sclerosis	0.00054	0.00109	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—CYP27B1—multiple sclerosis	0.000538	0.00109	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP24A1—multiple sclerosis	0.000538	0.00109	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL3—multiple sclerosis	0.000533	0.00108	CbGpPWpGaD
Bimatoprost—Nausea—Mitoxantrone—multiple sclerosis	0.000533	0.00107	CcSEcCtD
Bimatoprost—Infection—Prednisone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000531	0.00107	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00053	0.00106	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00053	0.00106	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000526	0.00107	CbGpPWpGaD
Bimatoprost—Pain—Dexamethasone—multiple sclerosis	0.000525	0.00105	CcSEcCtD
Bimatoprost—Pain—Betamethasone—multiple sclerosis	0.000525	0.00105	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—multiple sclerosis	0.000524	0.00105	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—multiple sclerosis	0.000519	0.00104	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—multiple sclerosis	0.000516	0.00104	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000513	0.00104	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TAGAP—multiple sclerosis	0.000513	0.00104	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RGS1—multiple sclerosis	0.00051	0.00103	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL5—multiple sclerosis	0.000502	0.00102	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TAGAP—multiple sclerosis	0.000502	0.00102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000495	0.001	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPC5—multiple sclerosis	0.000492	0.000997	CbGpPWpGaD
Bimatoprost—Vertigo—Methotrexate—multiple sclerosis	0.000492	0.000988	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCL5—multiple sclerosis	0.000492	0.000996	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CNR1—multiple sclerosis	0.00049	0.000992	CbGpPWpGaD
Bimatoprost—Dizziness—Prednisolone—multiple sclerosis	0.000486	0.000977	CcSEcCtD
Bimatoprost—Asthenia—Triamcinolone—multiple sclerosis	0.000485	0.000975	CcSEcCtD
Bimatoprost—Asthenia—Methylprednisolone—multiple sclerosis	0.000484	0.000973	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—TAGAP—multiple sclerosis	0.000484	0.00098	CbGpPWpGaD
Bimatoprost—Insomnia—Prednisone—multiple sclerosis	0.000483	0.000971	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—GPR65—multiple sclerosis	0.000483	0.000978	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCR2—multiple sclerosis	0.000482	0.000976	CbGpPWpGaD
Bimatoprost—Pruritus—Triamcinolone—multiple sclerosis	0.000479	0.000961	CcSEcCtD
Bimatoprost—Cough—Methotrexate—multiple sclerosis	0.000478	0.000959	CcSEcCtD
Bimatoprost—Pruritus—Methylprednisolone—multiple sclerosis	0.000477	0.000959	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—POMC—multiple sclerosis	0.000473	0.000958	CbGpPWpGaD
Bimatoprost—Dyspepsia—Prednisone—multiple sclerosis	0.00047	0.000945	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—multiple sclerosis	0.000466	0.000936	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000464	0.00094	CbGpPWpGaD
Bimatoprost—Rash—Prednisolone—multiple sclerosis	0.000464	0.000931	CcSEcCtD
Bimatoprost—Dermatitis—Prednisolone—multiple sclerosis	0.000463	0.000931	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000463	0.000929	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CCL2—multiple sclerosis	0.000463	0.000937	CbGpPWpGaD
Bimatoprost—Headache—Prednisolone—multiple sclerosis	0.000461	0.000925	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000455	0.000921	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000454	0.00092	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCR5—multiple sclerosis	0.000452	0.000916	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—S1PR1—multiple sclerosis	0.000448	0.000907	CbGpPWpGaD
Bimatoprost—Dizziness—Triamcinolone—multiple sclerosis	0.000447	0.000898	CcSEcCtD
Bimatoprost—Dizziness—Methylprednisolone—multiple sclerosis	0.000446	0.000896	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000445	0.000901	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CNR1—multiple sclerosis	0.000445	0.000901	CbGpPWpGaD
Bimatoprost—Infection—Methotrexate—multiple sclerosis	0.000444	0.000891	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR5—multiple sclerosis	0.000443	0.000897	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL13—multiple sclerosis	0.000442	0.000895	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR1—multiple sclerosis	0.000442	0.000895	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000441	0.000893	CbGpPWpGaD
Bimatoprost—Asthenia—Dexamethasone—multiple sclerosis	0.00044	0.000884	CcSEcCtD
Bimatoprost—Asthenia—Betamethasone—multiple sclerosis	0.00044	0.000884	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—S1PR1—multiple sclerosis	0.000439	0.000888	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Methotrexate—multiple sclerosis	0.000438	0.00088	CcSEcCtD
Bimatoprost—Nausea—Prednisolone—multiple sclerosis	0.000437	0.000877	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—GPC5—multiple sclerosis	0.000436	0.000883	CbGpPWpGaD
Bimatoprost—Pruritus—Betamethasone—multiple sclerosis	0.000434	0.000872	CcSEcCtD
Bimatoprost—Pruritus—Dexamethasone—multiple sclerosis	0.000434	0.000872	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—multiple sclerosis	0.000434	0.000871	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—GPC5—multiple sclerosis	0.000427	0.000864	CbGpPWpGaD
Bimatoprost—Rash—Triamcinolone—multiple sclerosis	0.000426	0.000857	CcSEcCtD
Bimatoprost—Dermatitis—Triamcinolone—multiple sclerosis	0.000426	0.000856	CcSEcCtD
Bimatoprost—Rash—Methylprednisolone—multiple sclerosis	0.000426	0.000855	CcSEcCtD
Bimatoprost—Dermatitis—Methylprednisolone—multiple sclerosis	0.000425	0.000854	CcSEcCtD
Bimatoprost—Headache—Triamcinolone—multiple sclerosis	0.000424	0.000851	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—S1PR1—multiple sclerosis	0.000423	0.000857	CbGpPWpGaD
Bimatoprost—Headache—Methylprednisolone—multiple sclerosis	0.000423	0.000849	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000422	0.000855	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000413	0.000837	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GPC5—multiple sclerosis	0.000412	0.000834	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000408	0.000826	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—RRM1—multiple sclerosis	0.000408	0.000826	CbGpPWpGaD
Bimatoprost—Dizziness—Dexamethasone—multiple sclerosis	0.000406	0.000815	CcSEcCtD
Bimatoprost—Dizziness—Betamethasone—multiple sclerosis	0.000406	0.000815	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—multiple sclerosis	0.000404	0.000811	CcSEcCtD
Bimatoprost—Nausea—Triamcinolone—multiple sclerosis	0.000402	0.000807	CcSEcCtD
Bimatoprost—Nausea—Methylprednisolone—multiple sclerosis	0.000401	0.000805	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL10—multiple sclerosis	0.0004	0.000811	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000399	0.000809	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL3—multiple sclerosis	0.000398	0.000807	CbGpPWpGaD
Bimatoprost—Dyspnoea—Methotrexate—multiple sclerosis	0.000398	0.0008	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—multiple sclerosis	0.000397	0.000798	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000397	0.000804	CbGpPWpGaD
Bimatoprost—Dyspepsia—Methotrexate—multiple sclerosis	0.000393	0.00079	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCL3—multiple sclerosis	0.00039	0.00079	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000388	0.000787	CbGpPWpGaD
Bimatoprost—Rash—Betamethasone—multiple sclerosis	0.000387	0.000777	CcSEcCtD
Bimatoprost—Rash—Dexamethasone—multiple sclerosis	0.000387	0.000777	CcSEcCtD
Bimatoprost—Dermatitis—Betamethasone—multiple sclerosis	0.000387	0.000777	CcSEcCtD
Bimatoprost—Dermatitis—Dexamethasone—multiple sclerosis	0.000387	0.000777	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000386	0.000775	CcSEcCtD
Bimatoprost—Headache—Dexamethasone—multiple sclerosis	0.000384	0.000772	CcSEcCtD
Bimatoprost—Headache—Betamethasone—multiple sclerosis	0.000384	0.000772	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000384	0.000777	CbGpPWpGaD
Bimatoprost—Asthenia—Prednisone—multiple sclerosis	0.000383	0.00077	CcSEcCtD
Bimatoprost—AKR1C3—Disease—RPL5—multiple sclerosis	0.000382	0.000774	CbGpPWpGaD
Bimatoprost—Pain—Methotrexate—multiple sclerosis	0.000382	0.000767	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—RGS1—multiple sclerosis	0.000381	0.000772	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCL5—multiple sclerosis	0.00038	0.000769	CbGpPWpGaD
Bimatoprost—Pruritus—Prednisone—multiple sclerosis	0.000378	0.000759	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000375	0.00076	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RGS1—multiple sclerosis	0.000373	0.000755	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCR3—multiple sclerosis	0.00037	0.00075	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000366	0.000742	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SLC11A1—multiple sclerosis	0.000366	0.000741	CbGpPWpGaD
Bimatoprost—Nausea—Betamethasone—multiple sclerosis	0.000365	0.000732	CcSEcCtD
Bimatoprost—Nausea—Dexamethasone—multiple sclerosis	0.000365	0.000732	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000363	0.000734	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—GPR65—multiple sclerosis	0.000361	0.000731	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCR2—multiple sclerosis	0.00036	0.00073	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RGS1—multiple sclerosis	0.00036	0.000729	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000358	0.000726	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000355	0.000718	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—POMC—multiple sclerosis	0.000354	0.000716	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—GPR65—multiple sclerosis	0.000354	0.000716	CbGpPWpGaD
Bimatoprost—Dizziness—Prednisone—multiple sclerosis	0.000353	0.00071	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCR2—multiple sclerosis	0.000353	0.000714	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000347	0.000703	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—POMC—multiple sclerosis	0.000346	0.000701	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL2—multiple sclerosis	0.000346	0.000701	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL5—multiple sclerosis	0.000345	0.000698	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000342	0.000693	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—GPR65—multiple sclerosis	0.000341	0.000691	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL2—multiple sclerosis	0.000339	0.000686	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000337	0.000683	CbGpPWpGaD
Bimatoprost—Rash—Prednisone—multiple sclerosis	0.000337	0.000677	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—multiple sclerosis	0.000337	0.000676	CcSEcCtD
Bimatoprost—Headache—Prednisone—multiple sclerosis	0.000335	0.000673	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CNR1—multiple sclerosis	0.000333	0.000673	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR1—multiple sclerosis	0.00033	0.000669	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL13—multiple sclerosis	0.00033	0.000669	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00033	0.000668	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CNR1—multiple sclerosis	0.000326	0.000659	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL13—multiple sclerosis	0.000323	0.000655	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR1—multiple sclerosis	0.000323	0.000655	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000323	0.000654	CbGpPWpGaD
Bimatoprost—Asthenia—Methotrexate—multiple sclerosis	0.00032	0.000644	CcSEcCtD
Bimatoprost—Nausea—Prednisone—multiple sclerosis	0.000317	0.000638	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000316	0.000641	CbGpPWpGaD
Bimatoprost—Pruritus—Methotrexate—multiple sclerosis	0.000316	0.000635	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CCL3—multiple sclerosis	0.000315	0.000637	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR1—multiple sclerosis	0.000312	0.000632	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL13—multiple sclerosis	0.000312	0.000632	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCR5—multiple sclerosis	0.000311	0.000629	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000306	0.00062	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTGER4—multiple sclerosis	0.000303	0.000614	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000299	0.000606	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PGR—multiple sclerosis	0.000298	0.000604	CbGpPWpGaD
Bimatoprost—Dizziness—Methotrexate—multiple sclerosis	0.000295	0.000593	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000293	0.000594	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCR3—multiple sclerosis	0.000293	0.000593	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD28—multiple sclerosis	0.000292	0.000592	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CD28—multiple sclerosis	0.00029	0.000587	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR2—multiple sclerosis	0.000285	0.000577	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000284	0.000575	CbGpPWpGaD
Bimatoprost—Rash—Methotrexate—multiple sclerosis	0.000282	0.000566	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—multiple sclerosis	0.000281	0.000565	CcSEcCtD
Bimatoprost—Headache—Methotrexate—multiple sclerosis	0.00028	0.000562	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000278	0.000563	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000273	0.000552	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000272	0.000551	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—POMC—multiple sclerosis	0.000267	0.000541	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000267	0.00054	CbGpPWpGaD
Bimatoprost—Nausea—Methotrexate—multiple sclerosis	0.000265	0.000533	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CNR1—multiple sclerosis	0.000263	0.000532	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL5—multiple sclerosis	0.000258	0.000522	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000256	0.000518	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL5—multiple sclerosis	0.000252	0.000511	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000252	0.00051	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR5—multiple sclerosis	0.00025	0.000507	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000248	0.000502	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000247	0.0005	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—POMC—multiple sclerosis	0.000243	0.000491	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL2—multiple sclerosis	0.000237	0.000481	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL10—multiple sclerosis	0.000237	0.000479	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL3—multiple sclerosis	0.000235	0.000477	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—BCHE—multiple sclerosis	0.000234	0.000474	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCR5—multiple sclerosis	0.000232	0.00047	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL3—multiple sclerosis	0.00023	0.000467	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000229	0.000463	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCR5—multiple sclerosis	0.000227	0.00046	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTGER4—multiple sclerosis	0.000227	0.000459	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000224	0.000454	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PGR—multiple sclerosis	0.000223	0.000452	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL3—multiple sclerosis	0.000222	0.00045	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTGER4—multiple sclerosis	0.000222	0.000449	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCR3—multiple sclerosis	0.000219	0.000443	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PGR—multiple sclerosis	0.000218	0.000442	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CD28—multiple sclerosis	0.000217	0.000439	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—TYK2—multiple sclerosis	0.000216	0.000437	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCR3—multiple sclerosis	0.000214	0.000434	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTGER4—multiple sclerosis	0.000214	0.000433	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR2—multiple sclerosis	0.000213	0.000431	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CD28—multiple sclerosis	0.000212	0.00043	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PGR—multiple sclerosis	0.000211	0.000427	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD86—multiple sclerosis	0.000209	0.000422	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR2—multiple sclerosis	0.000208	0.000422	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CD86—multiple sclerosis	0.000207	0.000419	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCR3—multiple sclerosis	0.000207	0.000419	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CD28—multiple sclerosis	0.000205	0.000415	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL5—multiple sclerosis	0.000204	0.000412	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR2—multiple sclerosis	0.000201	0.000407	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—POMC—multiple sclerosis	0.0002	0.000405	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2—multiple sclerosis	0.000198	0.0004	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CNR1—multiple sclerosis	0.000196	0.000398	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—POMC—multiple sclerosis	0.000196	0.000396	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CNR1—multiple sclerosis	0.000192	0.000389	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SPP1—multiple sclerosis	0.000189	0.000382	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CNR1—multiple sclerosis	0.000186	0.000376	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CCR5—multiple sclerosis	0.000185	0.000375	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR5—multiple sclerosis	0.000183	0.000371	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—POMC—multiple sclerosis	0.000181	0.000368	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2RA—multiple sclerosis	0.000181	0.000366	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HLA-A—multiple sclerosis	0.00018	0.000365	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2—multiple sclerosis	0.000179	0.000363	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—POMC—multiple sclerosis	0.000178	0.00036	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL2—multiple sclerosis	0.000178	0.00036	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL10—multiple sclerosis	0.000177	0.000358	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL2—multiple sclerosis	0.000174	0.000352	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL10—multiple sclerosis	0.000173	0.000351	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOE—multiple sclerosis	0.000168	0.000341	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL10—multiple sclerosis	0.000167	0.000338	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—APOE—multiple sclerosis	0.000167	0.000338	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—TYK2—multiple sclerosis	0.000161	0.000327	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—TYK2—multiple sclerosis	0.000158	0.00032	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CD86—multiple sclerosis	0.000155	0.000313	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL5—multiple sclerosis	0.000152	0.000308	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD80—multiple sclerosis	0.000152	0.000308	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CD86—multiple sclerosis	0.000151	0.000307	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CD80—multiple sclerosis	0.000151	0.000306	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL5—multiple sclerosis	0.000149	0.000302	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—multiple sclerosis	0.000148	0.000299	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CD86—multiple sclerosis	0.000146	0.000296	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—multiple sclerosis	0.000145	0.000293	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL5—multiple sclerosis	0.000144	0.000291	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—POMC—multiple sclerosis	0.000143	0.00029	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SPP1—multiple sclerosis	0.000141	0.000286	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APOE—multiple sclerosis	0.000141	0.000285	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL2—multiple sclerosis	0.00014	0.000284	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SPP1—multiple sclerosis	0.000138	0.00028	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000137	0.000278	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR5—multiple sclerosis	0.000137	0.000278	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2RA—multiple sclerosis	0.000135	0.000274	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR5—multiple sclerosis	0.000134	0.000272	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—multiple sclerosis	0.000134	0.000272	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—multiple sclerosis	0.000133	0.00027	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2RA—multiple sclerosis	0.000132	0.000268	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—multiple sclerosis	0.000131	0.000266	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR5—multiple sclerosis	0.00013	0.000262	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TYK2—multiple sclerosis	0.000128	0.00026	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2RA—multiple sclerosis	0.000128	0.000259	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TYK2—multiple sclerosis	0.000127	0.000258	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—APOE—multiple sclerosis	0.000125	0.000253	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—APOE—multiple sclerosis	0.000122	0.000247	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—POMC—multiple sclerosis	0.000121	0.000245	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—APOE—multiple sclerosis	0.000118	0.000239	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—multiple sclerosis	0.000116	0.000235	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CD80—multiple sclerosis	0.000113	0.000229	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CD80—multiple sclerosis	0.00011	0.000224	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—multiple sclerosis	0.00011	0.000224	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—POMC—multiple sclerosis	0.000107	0.000217	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CD80—multiple sclerosis	0.000107	0.000216	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—multiple sclerosis	0.000106	0.000215	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—multiple sclerosis	0.000105	0.000214	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—POMC—multiple sclerosis	0.000105	0.000213	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL2—multiple sclerosis	0.000105	0.000212	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL2—multiple sclerosis	0.000103	0.000208	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000103	0.000208	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—POMC—multiple sclerosis	0.000101	0.000205	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK1—multiple sclerosis	0.0001	0.000203	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—multiple sclerosis	0.0001	0.000203	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL2—multiple sclerosis	9.91e-05	0.000201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TYK2—multiple sclerosis	9.53e-05	0.000193	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TYK2—multiple sclerosis	9.32e-05	0.000189	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TYK2—multiple sclerosis	9e-05	0.000182	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—multiple sclerosis	8.99e-05	0.000182	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—multiple sclerosis	8.92e-05	0.000181	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—multiple sclerosis	8.36e-05	0.000169	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—multiple sclerosis	8.34e-05	0.000169	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—multiple sclerosis	8.29e-05	0.000168	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—multiple sclerosis	8.27e-05	0.000167	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK1—multiple sclerosis	8.18e-05	0.000166	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK1—multiple sclerosis	8.11e-05	0.000164	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—multiple sclerosis	7.93e-05	0.000161	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—multiple sclerosis	7.89e-05	0.00016	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—multiple sclerosis	7.76e-05	0.000157	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—multiple sclerosis	7.72e-05	0.000156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—multiple sclerosis	7.5e-05	0.000152	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—multiple sclerosis	7.48e-05	0.000152	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—multiple sclerosis	7.34e-05	0.000149	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—multiple sclerosis	7.08e-05	0.000143	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—multiple sclerosis	6.67e-05	0.000135	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—multiple sclerosis	6.53e-05	0.000132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—multiple sclerosis	6.3e-05	0.000128	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—multiple sclerosis	6.28e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—multiple sclerosis	6.23e-05	0.000126	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—multiple sclerosis	6.2e-05	0.000126	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—multiple sclerosis	6.18e-05	0.000125	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—multiple sclerosis	6.07e-05	0.000123	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK1—multiple sclerosis	6.06e-05	0.000123	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—multiple sclerosis	6.05e-05	0.000123	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK1—multiple sclerosis	5.93e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—multiple sclerosis	5.85e-05	0.000119	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—multiple sclerosis	5.84e-05	0.000118	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK1—multiple sclerosis	5.73e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—multiple sclerosis	4.66e-05	9.43e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—multiple sclerosis	4.56e-05	9.23e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—multiple sclerosis	4.4e-05	8.91e-05	CbGpPWpGaD
